Financial Contrast: Autonomix Medical (NASDAQ:AMIX) versus Vicarious Surgical (NYSE:RBOT)

Autonomix Medical (NASDAQ:AMIX) and Vicarious Surgical (NYSE:RBOT) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, institutional ownership, earnings and analyst recommendations.

Earnings & Valuation

This table compares Autonomix Medical and Vicarious Surgical”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Autonomix Medical	N/A	N/A	-$16.72 million	($3.55)	-0.11
Vicarious Surgical	N/A	N/A	-$63.22 million	($6.69)	-0.10

Autonomix Medical is trading at a lower price-to-earnings ratio than Vicarious Surgical, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

10.8% of Autonomix Medical shares are owned by institutional investors. Comparatively, 47.3% of Vicarious Surgical shares are owned by institutional investors. 6.2% of Autonomix Medical shares are owned by insiders. Comparatively, 9.5% of Vicarious Surgical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares Autonomix Medical and Vicarious Surgical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Autonomix Medical	N/A	-239.36%	-192.46%
Vicarious Surgical	N/A	-184.13%	-112.50%

Analyst Ratings

This is a summary of recent ratings and recommmendations for Autonomix Medical and Vicarious Surgical, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Autonomix Medical	1	1	1	0	2.00
Vicarious Surgical	1	2	0	0	1.67

Autonomix Medical presently has a consensus price target of $2.00, indicating a potential upside of 392.61%. Vicarious Surgical has a consensus price target of $7.00, indicating a potential upside of 907.48%. Given Vicarious Surgical’s higher probable upside, analysts plainly believe Vicarious Surgical is more favorable than Autonomix Medical.

Volatility & Risk

Autonomix Medical has a beta of -1.43, suggesting that its share price is 243% less volatile than the S&P 500. Comparatively, Vicarious Surgical has a beta of 1.75, suggesting that its share price is 75% more volatile than the S&P 500.

Summary

Vicarious Surgical beats Autonomix Medical on 7 of the 11 factors compared between the two stocks.

About Autonomix Medical

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.

About Vicarious Surgical

Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.